NASDAQ · EVGN
EVOGENE financials
$0.4100+7.89%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q4 '25 Dec 31 | Q4 '24 Dec 31 | Q4 '23 Dec 31 | Q4 '22 Dec 31 | Q4 '21 Dec 31 | Q4 '20 Dec 31 | Q4 '19 Dec 31 | Q4 '18 Dec 31 | Q4 '17 Dec 31 | Q4 '16 Dec 31 | Q1 '16 Mar 31 | Q4 '15 Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — | — | — | $2.0M | $2.5M |
| Gross profit | — | — | — | — | — | — | — | — | — | — | $501.0K | $457.0K |
| Gross margin | — | — | — | — | — | — | — | — | — | — | 24.9% | 18.6% |
| Operating income | — | — | — | — | — | — | — | — | — | — | -$4.6M | -$5.4M |
| Net income | — | — | — | — | — | — | — | — | — | — | -$3.4M | -$5.5M |
| Net margin | — | — | — | — | — | — | — | — | — | — | −167.3% | −222.2% |
| Diluted EPS | — | — | — | — | — | — | — | — | — | — | $-1.30 | $-2.20 |
| EBITDA | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | -$4.0M | -$5.4M |
| Operating cash flow | — | — | — | — | — | — | — | — | — | — | -$2.1M | -$4.4M |
| Free cash flow | — | — | — | — | — | — | — | — | — | — | -$2.4M | -$5.0M |
| Diluted shares | 7.9M | 5.7M | 4.6M | 4.1M | 40.4M | 28.2M | 25.8M | 25.8M | 25.7M | 25.4M | 2.5M | 2.5M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $13.0M | $15.3M | $20.8M | $29.0M | $32.3M | $46.2M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $6.4M | $18.5M | $0.00 |
| Total debt | $0.00 | $10.4M | $10.4M | $10.1M | $0.00 | $0.00 |
| Total assets | $20.0M | $39.9M | $51.1M | $56.1M | $76.3M | $71.9M |
| Total liabilities | $8.1M | $25.0M | $22.4M | $21.3M | $12.9M | $15.0M |
| Shareholders' equity | $12.0M | $14.8M | $28.7M | $34.8M | $63.4M | $56.9M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology